Guidelines for regulated cell death assays: a systematic summary, a categorical comparison, a prospective
X Hu, Z Li, R Lin, J Shan, Q Yu, R Wang… - Frontiers in cell and …, 2021 - frontiersin.org
Over the past few years, the field of regulated cell death continues to expand and novel
mechanisms that orchestrate multiple regulated cell death pathways are being unveiled …
mechanisms that orchestrate multiple regulated cell death pathways are being unveiled …
Toward unraveling the complexity of simple epithelial keratins in human disease
MB Omary, NO Ku, P Strnad… - The Journal of clinical …, 2009 - Am Soc Clin Investig
Simple epithelial keratins (SEKs) are found primarily in single-layered simple epithelia and
include keratin 7 (K7), K8, K18–K20, and K23. Genetically engineered mice that lack SEKs …
include keratin 7 (K7), K8, K18–K20, and K23. Genetically engineered mice that lack SEKs …
Interleukin-6 as a therapeutic target in human ovarian cancer
J Coward, H Kulbe, P Chakravarty, D Leader… - Clinical cancer …, 2011 - AACR
Purpose: We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in
ovarian cancer via abrogation of a tumor-promoting cytokine network. Experimental Design …
ovarian cancer via abrogation of a tumor-promoting cytokine network. Experimental Design …
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
JW Valle, H Wasan, A Lopes, AC Backen… - The Lancet …, 2015 - thelancet.com
Background Cisplatin and gemcitabine is the standard first-line chemotherapy regimen for
patients with advanced biliary tract cancer; expression of VEGF and its receptors is …
patients with advanced biliary tract cancer; expression of VEGF and its receptors is …
Translating cancer research into targeted therapeutics
JS de BONO, A Ashworth - Nature, 2010 - nature.com
The emphasis in cancer drug development has shifted from cytotoxic, non-specific
chemotherapies to molecularly targeted, rationally designed drugs promising greater …
chemotherapies to molecularly targeted, rationally designed drugs promising greater …
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy
Serological cell death biomarkers and circulating tumor cells (CTCs) have potential uses as
tools for pharmacodynamic blood-based assays and their subsequent application to early …
tools for pharmacodynamic blood-based assays and their subsequent application to early …
Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury
LP Bechmann, C Jochum, P Kocabayoglu, JP Sowa… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Predicting the probability of patients with acute liver failure (ALF) to
recover spontaneously is of major clinical importance. As apoptotic and necrotic cell death …
recover spontaneously is of major clinical importance. As apoptotic and necrotic cell death …
Highly sensitive detection of protein with aptamer-based target-triggering two-stage amplification
Z Zhang, C Zhang - Analytical chemistry, 2012 - ACS Publications
Highly sensitive detection of proteins is essential to biomedical research as well as clinical
diagnosis. However, so far most detection methods rely on antibody-based assays and are …
diagnosis. However, so far most detection methods rely on antibody-based assays and are …
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
J Cummings, F Raynaud, L Jones, R Sugar… - British journal of …, 2010 - nature.com
Clinical development of new anticancer drugs can be compromised by a lack of qualified
biomarkers. An indispensable component to successful biomarker qualification is assay …
biomarkers. An indispensable component to successful biomarker qualification is assay …
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
The tumor necrosis factor (TNF) superfamily member TNF-related apoptosis-inducing ligand
(TRAIL) induces apoptosis in cancer cells via death receptor (DR) activation with little toxicity …
(TRAIL) induces apoptosis in cancer cells via death receptor (DR) activation with little toxicity …